癌癥化療和藥理學(xué)在實(shí)驗(yàn)和臨床水平上解決了廣泛的藥理學(xué)和腫瘤學(xué)問(wèn)題。這一快速出版媒體的主要重點(diǎn)是新的抗癌藥物，他們的實(shí)驗(yàn)篩選，臨床前毒理學(xué)和藥理學(xué)，單一和聯(lián)合用藥模式，臨床一期，二期和三期試驗(yàn)。該雜志發(fā)表了以下領(lǐng)域的研究成果:臨床毒理學(xué)、藥物動(dòng)力學(xué)、藥效學(xué)、藥物相互作用和癌癥治療策略中的化療適應(yīng)癥。癌癥化療和藥理學(xué)是藥理學(xué)家和腫瘤學(xué)家的基本讀物。

Cancer Chemotherapy and Pharmacology addresses a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels. The primary focus of this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials.The journal publishes results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy. Cancer Chemotherapy and Pharmacology is essential reading for pharmacologists and oncologists.